Both in Pharmaceuticals
Elicio Therapeutics vs Impact BioMedical
Over the past year ELTX returned −83.0% and IBO returned −32.5%; their daily moves had a correlation of 0.00.
ELTX −83.0% IBO −32.5%Growth of $1, one year, split-adjusted
| Metric | ELTX | IBO |
|---|---|---|
| Price | $1.84 | $5.60 |
| Market cap | $48.4M | $47.8M |
| Today | −0.54% | −0.18% |
| 1 month | −35.2% | 0.0% |
| 6 months | −81.7% | −24.2% |
| Year to date | −76.9% | −12.1% |
| 1 year | −83.3% | −32.5% |
| Revenue growth (YoY) | — | −57.1% |
| Gross margin | — | −533.3% |
| Net margin | — | −23300.0% |
| P/E (TTM) | — | 60.6× |
| Price / sales | — | 1,367.0× |
| Net cash | $13.9M | $10.0K |
| Dividend yield | — | — |
| Volatility (60d) | 76.2% | 732.1% |
| Short % of float | 27.0% | 4.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).